• 54,029+ CME Conference Registrations Sold
  • 162,088+ Medical Conferences
  • 285 Specialties
  • 11,622 Organizers
  • 158,747 Speakers
  • 159 Countries
  • 4,828 Cities
Duration: CME/CE Points: Author(s):
-
CME : 0.25
Contact Hours : 0.25
CEUs : 0.025
MOC : 0.25
-

Matching Treatment Options to the Patient: The Role of Botulinum Toxin in Pediatric Patients with Spasticity is organized by CME Outfitters, LLC. 

Premiere Date: Thursday, June 11, 2020
Credit Expiration Date: Friday, June 11, 2021

This activity offers CE credit for:
• Physicians (CME)
• Pharmacists (ACPE)
• ABIM (MOC)
• Other

Credit Information:
CME Credit (Physicians):

CME Outfitters, LLC, designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CPE Credit (Pharmacists):
ACPECME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 0.25 contact hours (0.025 CEUs) Universal Activity Number:

ABIM/MOC Credit:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. 

Statement of Need:
Spasticity, a motor disorder characterized by a velocity-dependent increase in tonic stretch reflexes with exaggerated tendon jerks, results from hyper excitability of the stretch reflex. It often causes damage to one or more areas of the central nervous system; therefore, treatment goals should aim to provide symptom relief, ease patient care and decrease caregiver burden, and improve patient function. In order to accomplish these goals, it is imperative that clinicians develop individualized treatment strategies based on shared decision-making, available treatment options, and patient specific factors.

This CMEOCast podcast episode highlights how best to match treatment options with patients, with a specific focus on the safety and efficacy of botulinum toxin as a treatment for patients with spasticity.

Learning Objectives:
At the end of this CE activity, participants should be able to:
• Recognize the clinical manifestations of spasticity.
• Develop individualized treatment strategies based on shared goals, available treatment options and patient-specific factors.

The following learning objectives pertain only to those requesting CNE or CPE credit:
• Recognize the clinical manifestations of spasticity.
• Describe individualized treatment strategies based on shared goals, available treatment options and patient-specific factors.

Intended Audience

Physicians, PAs, nurse practitioners, and pharmacists.

Fees

Activity Fee : Fee Details will be updated soon
Interested

Specialties

Convert
Onsite to Virtual Conference

Market your online event to Million plus Healthcare professionals.

Recommended